Report - Syndromes Myélodysplasiques: nouveaux challenges · La fréquence des effets secondaires diminue avec le temps Cycles 1–2 (n = 175) Cycles 3–4 (n = 147) Cycles 4–5 (n = 130)

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form